US FDA Holds Steady With 58 Novel Approvals In 2025 Despite Upheaval

 
• By Bridget Silverman
  
perspectives 2026
FDA reviewers stayed on track during the tumult of 2025, with an approval count only three drugs fewer than in 2024 (Shutterstock)

More from Pink Sheet Perspectives

More from Pink Sheet